By Drug Target Review2025-10-15T09:00:07
AI has advanced molecule design, yet synthetic feasibility remains a bottleneck. Chemistry-first approaches offer a practical way forward.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2024-02-07T14:34:33
Sponsored by BellBrook Labs
2025-10-22T14:00:00
Sponsored by Wuxi Biologics
2025-04-22T14:58:00
Sponsored by Takara Bio USA
2023-07-04T09:00:08
Sponsored by SB Drug Discovery
2023-03-30T12:35:58
Sponsored by Sartorius
2023-06-29T09:19:53
Sponsored by BMG Labtech GmbH
Site powered by Webvision Cloud